Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 26, 2023; 11(27): 6579-6586
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6579
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6579
Figure 4 Enhanced computed tomography scan images during therapy.
A and B: 1 mo after combined toripalimab and anlotinib therapy, the esophagus lesion and metastatic lymph nodes shrunk; C and D: The tumor and metastatic lymph nodes were disappeared after 3 mo of combination therapy; E and F: The tumor and metastatic lymph nodes have been disappeared for up to 14 mo since the initiation of combination therapy.
- Citation: Chen SC, Ma DH, Zhong JJ. Combination therapy with toripalimab and anlotinib in advanced esophageal squamous cell carcinoma: A case report. World J Clin Cases 2023; 11(27): 6579-6586
- URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6579.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6579